Prevalence of opportunistic intestinal parasitic infections among HIV-infected patients with low CD4 cells counts in France in the combination antiretroviral therapy era  by Pavie, Juliette et al.
International Journal of Infectious Diseases 16 (2012) e677–e679Prevalence of opportunistic intestinal parasitic infections among HIV-infected
patients with low CD4 cells counts in France in the combination antiretroviral
therapy era§
Juliette Pavie a,*, Jean Menotti b, Raphae¨l Porcher c, Jean Luc Donay d, Se´bastien Gallien a,
Claudine Sarfati b, Francis Derouin b, Jean-Michel Molina a
aDepartment of Infectious Diseases, Saint-Louis Hospital and University of Paris Diderot Paris 7, 1 avenue Claude Vellefaux, 75010 Paris, France
b Laboratory of Parasitology, Saint-Louis Hospital and University of Paris Diderot Paris 7, Paris, France
cDepartment of biostatistics, Saint-Louis Hospital and University of Paris Diderot Paris 7, Paris, France
d Laboratory of Microbiology, Saint-Louis Hospital and University of Paris Diderot Paris 7, Paris, France
A R T I C L E I N F O
Article history:
Received 4 January 2012
Accepted 14 May 2012
Corresponding Editor: William Cameron,
Ottawa, Canada
Keywords:
Cryptosporidia
Microsporidia
Giardia
Diarrhea
AIDS
S U M M A R Y
Background: The use of combination antiretroviral therapy (cART) has dramatically reduced the
prevalence of opportunistic infections, however data on the prevalence of intestinal parasitic infections
in HIV-infected patients with low CD4 cell counts in the cART era are scarce.
Methods: We performed a prospective cohort study among HIV-infected patients with CD4 cell counts
<100/mm3 seen at a university hospital in Paris. Medical records were reviewed and stool samples were
obtained for macroscopic examination and detection of parasites including cryptosporidia and
microsporidia, whether or not the patient had diarrhea. Stool cultures were performed for patients with
diarrhea. Factors associated with the detection of parasites were then identiﬁed.
Results: Stools samples from 143 consecutive patients were analyzed. Patients were mostly men (76%),
and the median patient age was 41 years. The median CD4 cell count was 32/mm3, and 59% were
receiving cART. Diarrhea was present in 85 patients (59%), 19 of whom (22%) had intestinal parasites
detected in stools. Three patients with diarrhea were diagnosed with Salmonella typhimurium,
Campylobacter coli, and Clostridium difﬁcile infections. Among the 58 patients without diarrhea, parasitic
intestinal pathogens were still identiﬁed in six (10%). The overall prevalence of intestinal parasites was
17%, with cryptosporidia (n = 8), microsporidia (n = 6), and Giardia duodenalis (n = 5) being the most
frequent pathogens. Patients with intestinal parasites had diarrhea more often (76% vs. 56%, p = 0.025)
and were more often at US Centers for Disease Control and Prevention (CDC) clinical stage C (84% vs. 69%,
p = 0.024) than patients without parasites.
Conclusions: The prevalence of intestinal parasitic infections remains signiﬁcant in HIV-infected patients
with low CD4 counts in the cART era. A systematic search for parasitic pathogens including
microsporidia, cryptosporidia, and G. duodenalis should be performed even in the absence of diarrhea.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Since the introduction of combination antiretroviral therapy
(cART), the prevalence of opportunistic diseases has dramatically
decreased, especially gastrointestinal infections.1–4 However,
despite the use of cART, several HIV-infected patients still present
intestinal parasitic infections. Prevalence varies from country to§ This study was presented in part at the 11th European AIDS Clinical Society
meeting, Madrid, Spain, October 24–27, 2007.
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http://dx.doi.org/10.1016/j.ijid.2012.05.1022country, but most studies since the introduction of cART have been
conducted in low-resource settings.5–8
The purpose of this study was to assess the prevalence of
parasitic intestinal infections among HIV-infected patients with
low CD4 cell counts in France.
2. Methods
This prospective study was performed between May 2003 and
June 2006. All consecutive HIV-infected adults with CD4 cell
counts of less than 100/mm3 seen at the department of infectious
diseases of Saint Louis Hospital in Paris, France, were enrolled.
Whether or not patients were complaining of diarrhea, one
stool sample was obtained for macroscopic examination andses. Published by Elsevier Ltd. All rights reserved.
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least three loose or liquid stools in the previous 24 h), another stool
sample was obtained for bacterial stool culture with detection of
Clostridium difﬁcile toxin.
Stool samples were analyzed for the presence of ova and
parasites, as previously described.7 Cryptosporidia and micro-
sporidia spores were identiﬁed using appropriate staining
methods (modiﬁed Ziehl–Neelsen staining for cryptosporidia
and Uvitex 2B for microsporidia) and species identiﬁcation was
determined by PCR. When microsporidial spores typical of
Enterocytozoon bieneusi were detected, an E. bieneusi-speciﬁc
real-time PCR assay was performed to assess the parasite burden.
This assay was performed on an Applied Biosystems 7500 thermal
cycler (Applied Biosystems, Foster City, CA, USA) using FEB1 and
REB1 primers with a ﬂuorescent Taqman probe (50-ACGTGGGCGG-
GAGAAATCTTAGTGTTCGGG-30), which was labeled at the 50 end
with 6-carboxyﬂuorescein (FAM) and at the 30 end with 6-
carboxytetramethylrhodamine (TAMRA), as previously described.9
Species identiﬁcation of cryptosporidial spores was performed
using a PCR-restriction fragment length polymorphism (RFLP)
assay. Brieﬂy, DNA was extracted by using the High Pure PCR
Template Preparation Kit (Roche, Meylan, France), with a ﬁrst
incubation with proteinase K and tissue lysis buffer overnight a
55 8C, and the PCR-RFLP assay was performed as previously
described.10
Data collected for each patient were age, gender, geographic
origin, risk factor for HIV infection, US Centers for Disease Control
and Prevention (CDC) clinical stage, presence of diarrhea, CD4 and
CD8 cell counts, plasma HIV RNA level, and use of cART.
Patients with intestinal parasites in stool samples were
compared to those without parasites using Fisher’s exact test for
categorical variables and Wilcoxon signed-rank tests for numerical
variables, in order to identify factors associated with the detection
of parasites. A p-value of less than 0.05 was considered to indicate
statistical signiﬁcance. The statistical analysis was performed
using SAS software (SAS Institute).
3. Results
Stools samples from 143 consecutive patients were analyzed.
Patient characteristics are shown in Table 1. Patients were mostly
men (76%), and the median patient age was 41 years. The median
CD4 cell count was 32/mm3, and 59% were receiving cART.
Diarrhea was present in 85 patients (59%), 19 of whom (22%) had
intestinal parasites detected in stools. Bacterial stool cultures wereTable 1
Patient characteristics
All patients (N = 143) Pat
par
Age, median years 41 39 
Gender male, n (%) 109 (76%) 22 
Risk factor for HIV, n (%) 
Homosexual 55 (38%) 14 
Heterosexual 80 (56%) 11 
IV drug user 6 (4%) 0 
Unknown 2 (1%) 0 
Geographic origin, n (%) 
Europe 61 (43%) 16 
North Africa 12 (8%) 1 
Sub-Saharan Africa 47 (33%) 6 
Other 23 (16%) 2 
Stage C of CDC classiﬁcation, n (%) 103 (72%) 21 
Diarrhea, n (%) 85 (59%) 19 
Median CD4 cell count (cells/mm3) 32 26 
HIV RNA <50 copies/ml, n (%) 21 (15%) 2 
cART, n (%) 85 (59%) 14 
IV, intravenous; CDC, US Centers for Disease Control and Prevention; cART, combinatioperformed in 73 of these patients with diarrhea (86%) and three
patients were diagnosed with Salmonella typhimurium, Campylo-
bacter coli, and Clostridium difﬁcile infections. Among the 58
patients without diarrhea, parasitic intestinal pathogens were still
identiﬁed in six (10%). The overall prevalence of intestinal parasites
was therefore 17%, with cryptosporidia (n = 8), microsporidia
(n = 6), and Giardia duodenalis (n = 5) being the most frequent
pathogens.
Other intestinal parasites were: Isospora belli (n = 1), Entamoeba
histolytica/dispar (n = 3), ancylostoma and Strongyloides stercolaris
(n = 1), and Schistosoma mansoni (n = 1). Parasites identiﬁed among
the six patients without diarrhea were cryptosporidia (n = 1),
Giardia duodenalis (n = 2), ancylostoma and S. stercolaris (n = 1), E.
histolytica/dispar (n = 1), and S. mansoni (n = 1).
Different cryptosporidia species were identiﬁed in all but two
cases: Cryptosporidium hominis in four cases, Cryptosporidium
parvum in one case, and Cryptosporidium melagridis in one case.
All six stool specimens with microsporidia spores were
conﬁrmed by PCR as containing E. bieneusi DNA with a high
parasitic load (median 113 000 copies/ml, range 580–1 000 000
copies/ml).
Patients with intestinal parasites more often had diarrhea (76%
vs. 56%, p = 0.025) and were more often at CDC clinical stage C (84%
vs. 69%, p = 0.024) than patients without parasites (Table 1).
4. Discussion
The overall prevalence (17%) of intestinal parasitic infection in
this population of advanced HIV-infected patients in France in the
cART era remains quite signiﬁcant. The prevalence of intestinal
parasitic infections in HIV-infected patients from low income
countries ranges from 18% to 50%.7,11–16 The somewhat lower
prevalence reported in our study could be due to the fact that stool
examinations were performed whether or not the patients had
diarrhea. Indeed, the prevalence of intestinal parasites was nearly
two-fold higher in patients with diarrhea (22%) than in those
without diarrhea (10%). This prevalence of intestinal parasites
among patients with diarrhea could also be compared to that of a
study in Denmark among HIV-infected patients with higher CD4
cell counts (median of 515/mm3), in which despite 42% of patients
presenting with diarrhea, no parasites were detected in stools.17
Different intestinal parasites were found in our patients, but
opportunistic parasites (microsporidia, cryptosporidia, Giardia, S.
stercolaris, and I. belli) represented the vast majority of them
(21/25). Although the use of cART dramatically reduced theients with intestinal
asites (n = 25)
Patients without intestinal
parasites (n = 118)
p-Value
42 0.12
(88%) 87 (74%) 0.19
0.17
(56%) 41 (35%)
(44%) 69 (28%)
6 (5%)
2 (2%)
0.28
(64%) 45 (58%)
(4%) 11 (9%)
(24%) 41 (35%)
(8%) 21 (18%)
(84%) 82 (69%) 0.024
(76%) 66 (56%) 0.025
37 0.49
(8%) 19 (16%) 0.16
(56%) 71 (60%) 0.83
n antiretroviral therapy.
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Isospora, this decrease was largely due to the immune reconstitu-
tion after cART initiation.1,4,18–20 It is therefore not surprising that
in our study in which only 58% of patients were under cART and the
median patient CD4 count was only 32/mm3, we were still
encountering these parasitic pathogens.
In advanced HIV-infected patients with low CD4 counts, a
systematic search for parasitic pathogens including microsporidia
and cryptosporidia should still be performed in stools, even if the
patients do not complain of diarrhea. Indeed, 10% of patients
without diarrhea had intestinal parasites detected.
In conclusion, the overall prevalence of intestinal parasitic
infections in HIV-infected patients with low CD4 cell counts in this
study remained high despite the availability of cART. These data
emphasize the need to perform stool examinations for the
detection of parasites, particularly, but not only, in those with
diarrhea.
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